Premium
Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?
Author(s) -
Wild Sabine R.,
Moyakine Andre V.,
Vleuten Catharina J. M.
Publication year - 2019
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13941
Subject(s) - propranolol , medicine , involution (esoterism) , infantile hemangioma , quality of life (healthcare) , affect (linguistics) , hemangioma , pediatrics , surgery , nursing , psychology , neuroscience , consciousness , communication
This study compares the quality of life (QoL) of infantile hemangioma (IH) patients and their parents at the beginning of the involution phase with QoL in the growth phase. Additionally, the differences in QoL between propranolol‐treated patients and non‐treated patients are assessed. Overall, QoL seems to improve, even before involution occurs. Due to the efficacy of propranolol treatment, the impact on QoL remains relatively mild even in patients with severe IH.